Back
Alnylam Pharmaceuticals Vs. Apogee Enterprises Industry Stock Comparison
Sell
41
ALNY
Alnylam Pharmaceuticals
Last Price:
$240.65
Seasonality Move:
1.18%
Sell
28
APOG
Apogee Enterprises
Last Price:
$52.54
Seasonality Move:
5.76%
Sell
41
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $240.55. The Score for ALNY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Apogee Enterprises (APOG)
is a Sell
Is Apogee Enterprises a Buy, Sell or Hold?
-
The current Apogee Enterprises [APOG] share price is $52.52. The Score for APOG is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
APOG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $240.55Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
APOG Stock Price Chart
What is Apogee Enterprises's stock price today?
-
The Apogee Enterprises share price today is $52.52Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APOG is experiencing selling pressure, which indicates risk of future bearish movement.
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.88 | Sell |
Relative Strength Index (14 RSI): | 45.81 | Sell |
Chaikin Money Flow: | 585575 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (236.44 - 251.32) | Sell |
Bollinger Bands (100): | (245.87 - 280.49) | Sell |
APOG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.64 | Sell |
Relative Strength Index (14 RSI): | 11.6 | Sell |
Chaikin Money Flow: | -398167 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (66.86 - 81.36) | Sell |
Bollinger Bands (100): | (66.06 - 81.4) | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 235.86 | Buy |
20-day SMA: | 241.32 | Sell |
50-day SMA: | 252.53 | Sell |
200-day SMA: | 225.37 | Buy |
8-day EMA: | 237.3 | Buy |
20-day EMA: | 241.18 | Sell |
50-day EMA: | 249.76 | Sell |
200-day EMA: | 234.59 | Buy |
APOG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 67.43 | Sell |
20-day SMA: | 71.9 | Sell |
50-day SMA: | 77.92 | Sell |
200-day SMA: | 67.99 | Sell |
8-day EMA: | 65.13 | Sell |
20-day EMA: | 70.76 | Sell |
50-day EMA: | 74.46 | Sell |
200-day EMA: | 68.5 | Sell |
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $4.76 per share.
Apogee Enterprises Earnings Growth & APOG Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.35 per share, and a decrease next year of $0.76 per share.
Alnylam Pharmaceuticals Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apogee Enterprises Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |